Australia's most trusted
source of pharma news
Wednesday, 24 June 2026
Wednesday, 24 June 2026
Subscribe
Login
News Headlines
News Headlines
News
AbbVie pays big for major market
Posted 24 June 2026 AM
AbbVie is boosting its atopic dermatitis portfolio with its biggest acquisition in more than half a decade, which will allow it to take a tilt at a half-billion dollar market in Australia.
The $15.6 billion (US$10.9 billion) all cash deal to buy Apogee Therapeutics will give it control of lead asset zumilokibart, a subcutaneous, half-life extended, monoclonal antibody targeting IL-13 for patients with atopic dermatitis which AbbVie thinks may be best-in-category with mega-blockbuster potential. It's due to start Phase 3 trials in the second half of this year.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (20)
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
- Strategic Sales Director ANZ, Digital Health - Sydney
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Sales Manager / Territory Manager - Christchurch
Access & Reimbursement (2)
- Head of Access, Sustainability & External Engagement - Melbourne
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
Clinical & Medical, R&D (8)
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Clinical Trial Investigator - Melbourne
- Senior Medical Manager - Melbourne
Regulatory, Pharmacovigilance & QA (6)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Other (9)
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.